PAREXEL® Clinical Development Optimization Using Scenario Planning

December 16, 2016
The unacceptably high Phase III clinical trial failure rates are well-known challenges in the pharmaceutical industry. The root causes are numerous and diverse. The ability to design better protocols to select the right patients, sites and countries are key success factors. Watch this webcast to learn what leading companies are doing to mitigate the risk of failure. For more information: www.PAREXEL.com/CDO
Previous Video
Latest Insights of Managed Access Programs
Latest Insights of Managed Access Programs

Hear from Peggy Schrammel, Vice President of Managed Access Programs describe the intricacies of performing...

Next Video
PAREXEL's IMPACT® Clinical Development Platform
PAREXEL's IMPACT® Clinical Development Platform

PAREXEL's IMPACT® Clinical Development Platform, provides a single integrated solution, designed to transfo...